Author:
Magne Julien,Henri Christine,Lancellotti Patrizio
Reference50 articles.
1. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology, European Association for Cardio-Thoracic Surgery, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J. 2012;33(19):2451–96. PubMed PMID: 22922415.
2. Trichon BH, Felker GM, Shaw LK, Cabell CH, O’Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91(5):538–43. PubMed PMID: 12615256.
3. Pu M, Thomas JD, Gillinov MA, Griffin BP, Brunken RC. Importance of ischemic and viable myocardium for patients with chronic ischemic mitral regurgitation and left ventricular dysfunction. Am J Cardiol. 2003;92(7):862–4. PubMed PMID: 14516895.
4. Penicka M, Linkova H, Lang O, Fojt R, Kocka V, Vanderheyden M, et al. Predictors of improvement of unrepaired moderate ischemic mitral regurgitation in patients undergoing elective isolated coronary artery bypass graft surgery. Circulation. 2009;120(15):1474–81. PubMed PMID: 19786637.
5. Mihaljevic T, Gillinov AM, Sabik 3rd JF. Functional ischemic mitral regurgitation: myocardial viability as a predictor of postoperative outcome after isolated coronary artery bypass grafting. Circulation. 2009;120(15):1459–61. PubMed PMID: 19786629.